Skip to main content
SpringerLink
Log in

Lung Cancer

  • Chapter
  • First Online:
Intraoperative Irradiation

Part of the book series: Current Clinical Oncology ((CCO))

  • 739 Accesses

Abstract

Small cell lung cancer (SCLC) is considered as high-risk metastatic disease potential at the time of diagnosis, and combined modality therapy with chemotherapy and thoracic external beam irradiation (EBRT) is the treatment of choice. Surgery for patients with SCLC could probably be reserved for stage I disease. Patients with more advanced SCLC are not considered to be surgical candidates and early EBRT obtains acceptable thoracic control rates. Intraoperative irradiation (IORT) has not been reported in this tumor histology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Johnson DH, Einhorn LH, Bartolucci A, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med. 1990;113:33–8.

    PubMed  CAS  Google Scholar 

  2. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer. 1987;59:1874–81.

    Article  PubMed  CAS  Google Scholar 

  3. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210–5.

    Article  PubMed  CAS  Google Scholar 

  4. Cox J. Analysis of inoperable carcinoma of the lung of all histopathologic types and squamos cell carcinoma of the esophagus. Cancer Treat Symp. 1983;2:77–86.

    Google Scholar 

  5. Le Chevalier CT, Arriagada R. Quoix et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst. 1991;83:417–23.

    Article  PubMed  Google Scholar 

  6. Emami B, Perez CA. Carcinoma of the lung. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia, PA: Lippincot; 1987. p. 650–83.

    Google Scholar 

  7. Perez CA, Bauer M, Edelstein S, et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys. 1986;12:539–47.

    Article  PubMed  CAS  Google Scholar 

  8. Cox JD, Azarnia N, Byhardt RW, et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 1990;8:1543–55.

    PubMed  CAS  Google Scholar 

  9. Cox JD, Pajak TF, Herskovic A, et al. Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08. Am J Clin Oncol. 1991;14:280–4.

    Article  PubMed  CAS  Google Scholar 

  10. Byhardt RW, Pajak TF, Emami B, et al. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07. Int J Radiat Oncol Biol Phys. 1993;26:459–68.

    Article  PubMed  CAS  Google Scholar 

  11. Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst. 1995;87:198–205.

    Article  PubMed  CAS  Google Scholar 

  12. Kunitoh H, Kato H, Tsuboi M, et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol. 2008;26:644–9.

    Article  PubMed  CAS  Google Scholar 

  13. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 2007;25:313–8.

    Article  PubMed  Google Scholar 

  14. Garrido P, Gonzalez-Larriba JL, Insa A, et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol. 2007;25:4736–42.

    Article  PubMed  Google Scholar 

  15. Gottfried M, Ramlau R, Krzakowski M, et al. Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results. J Thorac Oncol. 2008;3:152–7.

    Article  PubMed  Google Scholar 

  16. Thomas M, Rube C, Hoffknecht P, et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol. 2008;9:636–48.

    Article  PubMed  Google Scholar 

  17. van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst. 2007;99:442–50.

    Article  PubMed  Google Scholar 

  18. NCCN Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. v.2.2009. 2009. www.nccn.org. Accesed June 2009.

  19. D’Addario G, Felip E. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19 Suppl 2:ii39–40.

    Article  PubMed  Google Scholar 

  20. Jett JR, Schild SE, Keith RL, et al. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:266S–76.

    Article  PubMed  Google Scholar 

  21. Robinson LA, Ruckdeschel JC, Wagner Jr H, et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:243S–65.

    Article  PubMed  Google Scholar 

  22. Shen KR, Meyers BF, Larner JM, et al. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:290S–305.

    Article  PubMed  Google Scholar 

  23. Gunderson LL. Rationale for and results of intraoperative radiation therapy. Cancer. 1994;74:537–41.

    Article  PubMed  CAS  Google Scholar 

  24. Calvo FA, Santos M, de Ortiz UD, et al. Intraoperative radiotherapy in thoracic tumors. Front Radiat Ther Oncol. 1991;25:307–16.

    PubMed  CAS  Google Scholar 

  25. Wagner H. Image-guided conformal radiation therapy planning and delivery for non-small-cell lung cancer. Cancer Control. 2003;10:277–88.

    PubMed  Google Scholar 

  26. Liao ZX, Komaki RR, Thames HD, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010;76:775–81.

    Article  PubMed  Google Scholar 

  27. Aristu J, Rebollo J, Martinez-Monge R, et al. Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small cell lung cancer: final results of a phase II study. Am J Clin Oncol. 1997;20:276–81.

    Article  PubMed  CAS  Google Scholar 

  28. Calvo FA, de Ortiz UD, Abuchaibe O, et al. Intraoperative radiotherapy during lung cancer surgery: technical description and early clinical results. Int J Radiat Oncol Biol Phys. 1990;19:103–9.

    PubMed  CAS  Google Scholar 

  29. Barnes M, Pass H, DeLuca A, et al. Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy (IORT). Int J Radiat Oncol Biol Phys. 1987;13:371–8.

    Article  PubMed  CAS  Google Scholar 

  30. de Boer WJ, Mehta DM, Timens W, et al. The short and long term effects of intraoperative electron beam radiotherapy (IORT) on thoracic organs after pneumonectomy an experimental study in the canine model. Int J Radiat Oncol Biol Phys. 1999;45:501–6.

    Article  PubMed  Google Scholar 

  31. Pass HI, Sindelar WF, Kinsella TJ, et al. Delivery of intraoperative radiation therapy after pneumonectomy: experimental observations and early clinical results. Ann Thorac Surg. 1987;44:14–20.

    Article  PubMed  CAS  Google Scholar 

  32. Tochner ZA, Pass HI, Sindelar WF, et al. Long term tolerance of thoracic organs to intraoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1992;22:65–9.

    Article  PubMed  CAS  Google Scholar 

  33. Sindelar WF, Hoekstra HJ, Kinsella TJ, et al. Response of canine esophagus to intraoperative electron beam radiotherapy. Int J Radiat Oncol Biol Phys. 1988;15:663–9.

    Article  PubMed  CAS  Google Scholar 

  34. Zhou GX, Zhang CW, Li WH. Acute responses of the mediastinal and thoracic viscera of canine to intraoperative irradiation. In: Schmitt JM, Wu Q, and Krämling HJ, editors. Intraoperative radiation therapy. Proccedings Fourth International Symposium, Munich; 1992. p. 50–2.

    Google Scholar 

  35. Kritskaia NG, Dobrodeev AI, Zav’ialov AA, et al. Morphofunctional changes in the bronchial epithelium in combined therapy for lung cancer. Arkh Patol. 2006;68:10–4.

    PubMed  CAS  Google Scholar 

  36. Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys. 1981;7:863–8.

    Article  PubMed  CAS  Google Scholar 

  37. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg. 1992;53:992–8.

    Article  PubMed  CAS  Google Scholar 

  38. Juettner FM, Arian-Schad K, Porsch G, et al. Intraoperative radiation therapy combined with external irradiation in nonresectable non-small-cell lung cancer: preliminary report. Int J Radiat Oncol Biol Phys. 1990;18:1143–50.

    Article  PubMed  CAS  Google Scholar 

  39. Arian-Schad KS, Juettner FM, Ratzenhofer B, et al. Intraoperative plus external beam irradiation in nonresectable lung cancer: assessment of local response and therapy-related side effects. Radiother Oncol. 1990;19:137–44.

    Article  PubMed  CAS  Google Scholar 

  40. Smolle-Juettner FM, Geyer E, Kapp KS, et al. Evaluating intraoperative radiation therapy (IORT) and external beam radiation therapy (EBRT) in non-small cell lung cancer (NSCLC). Five years experience. Eur J Cardiothorac Surg. 1994;8:511–6.

    Article  PubMed  CAS  Google Scholar 

  41. Jakse G, Kapp KS, Geyer E, et al. IORT and external beam irradiation (EBI) in clinical stage I-II NSCLC patients with severely compromised pulmonary function: an 52-patient single-institutional experience. Strahlenther Onkol. 2007;183(Spec No 2):24–5.

    Article  PubMed  Google Scholar 

  42. Carter YM, Jablons DM, DuBois JB, et al. Intraoperative radiation therapy in the multimodality approach to upper aerodigestive tract cancer. Surg Oncol Clin N Am. 2003;12:1043–63.

    Article  PubMed  Google Scholar 

  43. Aristu J, Calvo FA, Martinez-Monge R, et al. Lung cancer: EBRT with or without IORT. In: Gunderson LL, Willet CG, Harrison LB, Calvo FA, editors. Intraoperative irradiation-techniques and results. Totowa, NJ: Humana; 1999. p. 437–54.

    Google Scholar 

  44. Calvo FA, de Ortiz UD, Herreros J, et al. Lung cancer. In: Calvo FA, Santos M, Brady L, editors. Intraoperative radiotherapy. Clinical experiences and results. Berlin: Springer; 1992. p. 43–50.

    Google Scholar 

  45. Martinez-Monge R, Herreros J, Aristu JJ, et al. Combined treatment in superior sulcus tumors. Am J Clin Oncol. 1994;17:317–22.

    Article  PubMed  CAS  Google Scholar 

  46. Fisher S, Fallahnejad M, Lisker S, et al. Role of intraoperative radiation therapy (IORT) for stage III non small cell lung cancer. Hepatogastroenterology. 1994;41:15 (abst).

    Google Scholar 

  47. d’Amato TA, Galloway M, Szydlowski G, et al. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest. 1998;114:1112–5.

    Article  PubMed  Google Scholar 

  48. Nori D, Li X, Pugkhem T. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study. J Surg Oncol. 1995;60:257–61.

    Article  PubMed  CAS  Google Scholar 

  49. Hilaris BS, Mastoras DA. Contemporary brachytherapy approaches in non-small-cell lung cancer. J Surg Oncol. 1998;69:258–64.

    Article  PubMed  CAS  Google Scholar 

  50. Fleischman EH, Kagan AR, Streeter OE, et al. Iodine125 interstitial brachytherapy in the treatment of carcinoma of the lung. J Surg Oncol. 1992;49:25–8.

    Article  PubMed  CAS  Google Scholar 

  51. Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–7.

    Article  PubMed  Google Scholar 

  52. Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003;75:237–42.

    Article  PubMed  Google Scholar 

  53. Chen A, Galloway M, Landreneau R, et al. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys. 1999;44:1057–63.

    Article  PubMed  CAS  Google Scholar 

  54. Voynov G, Heron DE, Lin CJ, et al. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy. 2005;4:278–85.

    Article  PubMed  Google Scholar 

  55. Valero J, Martinez-Monge Rj, Pagola M, et al. Rescate quirúrgico con técnicas de braquiterapia intraoperatoria en cáncer de pulmón con enfermedad residual tras tratamiento quimiorradioterápico o con enfermedad recurrente tras radioterapia previa. Clin Transl Oncol. 2007;9[Extraordinary 3]:5 (abst).

    Google Scholar 

  56. Hilaris BS, Nori D. The role of external radiation and brachytherapy in unresectable non-small cell lung cancer. Surg Clin North Am. 1987;67:1061–71.

    PubMed  CAS  Google Scholar 

  57. Hilaris BS, Nori D, Beattie Jr EJ, et al. Value of perioperative brachytherapy in the management of non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1983;9:1161–6.

    Article  PubMed  CAS  Google Scholar 

  58. Hilaris BS, Gomez J, Nori D, et al. Combined surgery, intraoperative brachytherapy, and postoperative external radiation in stage III non-small cell lung cancer. Cancer. 1985;55:1226–31.

    Article  PubMed  CAS  Google Scholar 

  59. Burt ME, Pomerantz AH, Bains MS, et al. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am. 1987;67:987–1000.

    PubMed  CAS  Google Scholar 

  60. van Geel AN, Jansen PP, van Klaveren RJ, et al. High relapse-free survival after preoperative and intraoperative radiotherapy and resection for sulcus superior tumors. Chest. 2003;124:1841–6.

    Article  PubMed  Google Scholar 

  61. Hilaris BS, Martini N, Luomanen RK, et al. The value of preoperative radiation therapy in apical cancer of the lung. Surg Clin North Am. 1974;54:831–40.

    PubMed  CAS  Google Scholar 

  62. Hilaris BS, Martini N, Wong GY, et al. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am. 1987;67:965–77.

    PubMed  CAS  Google Scholar 

  63. Kumar P, Herndon J, Langer M, et al. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Cancer. 1996;77:2393–9.

    Article  PubMed  CAS  Google Scholar 

  64. Choi NC, Carey RW, Daly W, et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol. 1997;15:712–22.

    PubMed  CAS  Google Scholar 

  65. Robertson JM, Ten Haken RK, Hazuka MB, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1079–85.

    Article  PubMed  CAS  Google Scholar 

  66. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-Year Results of a Prospective Phase II Study. Int J Radiat Oncol Biol Phys. 2009;75:677–82.

    Article  PubMed  Google Scholar 

  67. Lo SS, Fakiris AJ, Papiez L, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Expert Rev Anticancer Ther. 2008;8:87–98.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Navarra University Clinic, Pamplona, Spain

    Javier Aristu, Marta Moreno, Rafael Martínez & María Esperanza Rodriguez

  2. Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    Felipe A. Calvo

  3. Department of Cardiovascular Surgery, Navarra University Clinic, Pamplona, Spain

    Jesús Herreros

  4. Radiotherapy Service, Centre Regional de Lutte Contre Le Cancer, Montpellier, France

    Jean-Bernard DuBois

  5. Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, USA

    Scott Fisher

Authors
  1. Javier Aristu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Felipe A. Calvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marta Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rafael Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jesús Herreros
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. María Esperanza Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jean-Bernard DuBois
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Scott Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier Aristu .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Mayo Clinic, East Shea Blvd 13400, Scottsdale, 85259, Arizona, USA

    Leonard L. Gunderson

  2. Dept. Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA

    Christopher G. Willett

  3. Gregorio Marañón, Depto. Radiación de Oncología, Hospital General Universitario, C/ Dr. Esquerdo 46, Madrid, 28007, Spain

    Felipe A. Calvo

  4. Albert Einstein College of Medicine, Radiation Oncology, Beth Israel Medical Center, Union Square East 10, New York, 10003, New York, USA

    Louis B. Harrison

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Aristu, J. et al. (2011). Lung Cancer. In: Gunderson, L., Willett, C., Calvo, F., Harrison, L. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-61779-015-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-015-7_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-014-0

  • Online ISBN: 978-1-61779-015-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation